Cardlytics Net Income
| CDLX Stock | USD 0.94 0.01 0.75% |
As of the 10th of February, Cardlytics shows the Standard Deviation of 6.61, risk adjusted performance of (0.08), and Mean Deviation of 4.8. Cardlytics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Cardlytics Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.9016 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -170.4 M | -178.9 M | |
| Net Loss | -418.7 M | -397.8 M | |
| Net Loss | -170.4 M | -178.9 M | |
| Net Loss | (3.52) | (3.70) | |
| Net Income Per E B T | 1.15 | 1.08 |
Cardlytics | Net Income | Build AI portfolio with Cardlytics Stock |
The evolution of Net Income for Cardlytics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Cardlytics compares to historical norms and industry peers.
Latest Cardlytics' Net Income Growth Pattern
Below is the plot of the Net Income of Cardlytics over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Cardlytics financial statement analysis. It represents the amount of money remaining after all of Cardlytics operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Cardlytics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (189.3 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Cardlytics Net Income Regression Statistics
| Arithmetic Mean | (101,870,346) | |
| Coefficient Of Variation | (108.03) | |
| Mean Deviation | 77,162,212 | |
| Median | (53,042,000) | |
| Standard Deviation | 110,053,428 | |
| Sample Variance | 12111.8T | |
| Range | 448.1M | |
| R-Value | (0.60) | |
| Mean Square Error | 8336T | |
| R-Squared | 0.35 | |
| Significance | 0.01 | |
| Slope | (12,980,805) | |
| Total Sum of Squares | 193788.1T |
Cardlytics Net Income History
Other Fundumenentals of Cardlytics
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Cardlytics Net Income component correlations
Cardlytics Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Cardlytics is extremely important. It helps to project a fair market value of Cardlytics Stock properly, considering its historical fundamentals such as Net Income. Since Cardlytics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cardlytics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cardlytics' interrelated accounts and indicators.
Click cells to compare fundamentals
Is Advertising space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardlytics. Projected growth potential of Cardlytics fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cardlytics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.57) | Earnings Share (2.06) | Revenue Per Share | Quarterly Revenue Growth (0.22) | Return On Assets |
The market value of Cardlytics is measured differently than its book value, which is the value of Cardlytics that is recorded on the company's balance sheet. Investors also form their own opinion of Cardlytics' value that differs from its market value or its book value, called intrinsic value, which is Cardlytics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardlytics' market value can be influenced by many factors that don't directly affect Cardlytics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Cardlytics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cardlytics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Cardlytics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cardlytics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cardlytics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cardlytics.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Cardlytics on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Cardlytics or generate 0.0% return on investment in Cardlytics over 90 days. Cardlytics is related to or competes with Baosheng Media, Cheetah Mobile, Onfolio Holdings, Cheer Holding, Locafy, and Software Acquisition. Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom More
Cardlytics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cardlytics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cardlytics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 29.56 | |||
| Value At Risk | (9.43) | |||
| Potential Upside | 10.71 |
Cardlytics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardlytics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cardlytics' standard deviation. In reality, there are many statistical measures that can use Cardlytics historical prices to predict the future Cardlytics' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (1.46) | |||
| Treynor Ratio | (0.24) |
Cardlytics February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.23) | |||
| Mean Deviation | 4.8 | |||
| Coefficient Of Variation | (921.02) | |||
| Standard Deviation | 6.61 | |||
| Variance | 43.68 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (1.46) | |||
| Treynor Ratio | (0.24) | |||
| Maximum Drawdown | 29.56 | |||
| Value At Risk | (9.43) | |||
| Potential Upside | 10.71 | |||
| Skewness | (0.75) | |||
| Kurtosis | 3.83 |
Cardlytics Backtested Returns
Cardlytics secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11 % return per unit of risk over the last 3 months. Cardlytics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cardlytics' Risk Adjusted Performance of (0.08), mean deviation of 4.8, and Standard Deviation of 6.61 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 3.04, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardlytics will likely underperform. At this point, Cardlytics has a negative expected return of -0.61%. Please make sure to confirm Cardlytics' jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Cardlytics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.40 |
Average predictability
Cardlytics has average predictability. Overlapping area represents the amount of predictability between Cardlytics time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cardlytics price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Cardlytics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | 0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Cardlytics Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Cardlytics reported net income of (189.3 Million). This is 111.87% lower than that of the Media sector and significantly lower than that of the Communication Services industry. The net income for all United States stocks is 133.15% higher than that of the company.
Cardlytics Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cardlytics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cardlytics could also be used in its relative valuation, which is a method of valuing Cardlytics by comparing valuation metrics of similar companies.Cardlytics is currently under evaluation in net income category among its peers.
Cardlytics Institutional Holders
Institutional Holdings refers to the ownership stake in Cardlytics that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Cardlytics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cardlytics' value.| Shares | D. E. Shaw & Co Lp | 2025-06-30 | 504.9 K | Bank Of America Corp | 2025-06-30 | 410.2 K | Landscape Capital Management,llc | 2025-06-30 | 400 K | Gsa Capital Partners Llp | 2025-06-30 | 358.6 K | Acorn Financial Advisory Services Inc | 2025-06-30 | 326.2 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 325.5 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 309.3 K | Charles Schwab Investment Management Inc | 2025-06-30 | 269.7 K | Brooktree Capital Management Inc | 2025-06-30 | 242.2 K | Vanguard Group Inc | 2025-06-30 | 2.4 M | 683 Capital Management Llc | 2025-06-30 | 1.6 M |
Cardlytics Fundamentals
| Return On Equity | -3.41 | ||||
| Return On Asset | -0.09 | ||||
| Profit Margin | (0.44) % | ||||
| Operating Margin | (0.19) % | ||||
| Current Valuation | 226.46 M | ||||
| Shares Outstanding | 54.06 M | ||||
| Shares Owned By Insiders | 2.95 % | ||||
| Shares Owned By Institutions | 42.75 % | ||||
| Number Of Shares Shorted | 5.88 M | ||||
| Price To Earning | (3.47) X | ||||
| Price To Book | 2.15 X | ||||
| Price To Sales | 0.20 X | ||||
| Revenue | 278.3 M | ||||
| Gross Profit | 111.46 M | ||||
| EBITDA | (152.53 M) | ||||
| Net Income | (189.3 M) | ||||
| Cash And Equivalents | 157.04 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 221.65 M | ||||
| Debt To Equity | 0.42 % | ||||
| Current Ratio | 0.90 X | ||||
| Book Value Per Share | (0.09) X | ||||
| Cash Flow From Operations | (8.82 M) | ||||
| Short Ratio | 6.09 X | ||||
| Earnings Per Share | (2.06) X | ||||
| Price To Earnings To Growth | (0.24) X | ||||
| Target Price | 1.63 | ||||
| Number Of Employees | 367 | ||||
| Beta | 1.03 | ||||
| Market Capitalization | 48.99 M | ||||
| Total Asset | 392.71 M | ||||
| Retained Earnings | (1.3 B) | ||||
| Working Capital | 29.03 M | ||||
| Current Asset | 81.93 M | ||||
| Current Liabilities | 52.77 M | ||||
| Net Asset | 392.71 M |
About Cardlytics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cardlytics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardlytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardlytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.